|
Age
|
Median 10 Years (Range 6–14 years)
|
|
Gender
|
7 Spayed Female
|
|
6 Neutered Male
|
|
2 Intact Male
|
|
Breed
|
4 Scottish Terriers
|
|
3 Mixed Breed
|
|
3 Beagles
|
|
2 Shetland Sheepdogs, 1 West Highland White Terrier, 1 German Shorthaired Pointer, 1 Miniature Pinscher
|
|
TNM Stage at Tissue Collection
|
T2N0M0–5 Dogs
|
|
T2N0M1–4 Dogs
|
|
T2N1M1–2 Dogs
|
|
T3N0M0–1 Dog
|
|
T3N1M0–1 Dog
|
|
T3N1M1–1 Dog
|
|
Prior Therapy
|
8 Dogs Had Prior Therapy Including: a Cyclooxygenase Inhibitor (7 Dogs), Leukeran (3 Dogs), Vinblastine-Folate Conjugate (2 Dogs), Vinblastine (1 Dog), Carboplatin (1 Dog), 5 Azacitidine (1 Dog), Intravesical Mitomycin C (1 Dog)
|
|
Tissue Collection Method
|
5 tumor tissues were collected by cystoscopy, 10 tumor tissues were collected at necropsy
|
|
Mutation Status of Tumor
|
11 tumors carried the BRAFV595E mutation, 4 tumors had no BRAF mutation
|
